HARP - Harpoon Therapeutics EPS misses by $0.09 beats on revenue November, 06 2019 05:09 PM Harpoon Therapeutics Inc. Harpoon Therapeutics (NASDAQ:HARP): Q3 GAAP EPS of -$0.65 misses by $0.09.More news on: Harpoon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...